Skip to main content

Ross Thomas M.'s Form 4 filing

Maxcyte, Inc.MXCT · filed Aug 5, 2024

Accession no.
0001415889-24-020785
Filed
Aug 5, 2024
Trade date
Aug 1-2, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $148.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ross Thomas M.CIK 0001874572Officer (EVP, GLOBAL SALES)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2024Common StockMOption exerciseAcquired+15,476$1.64+$25,380.6440,476Direct
Aug 1, 2024Common StockSSaleDisposed−15,476$4.54F2−$70,261.0425,000Direct
Aug 2, 2024Common StockMOption exerciseAcquired+17,857$1.64+$29,285.4842,857Direct
Aug 2, 2024Common StockSSaleDisposed−17,857$4.36F3−$77,856.5225,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 1, 2024Common StockMOption exerciseDisposed−15,476$0.00$017,858Direct
Aug 2, 2024Common StockMOption exerciseDisposed−17,857$0.00$01Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.445 to $4.805, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.235 to $4.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)